SAN CARLOS, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical today shared new field data from D. Kyle Hogarth, MD (University of Chicago Medical Center) and Amit Mahajan, MD (Inova Fairfax Hospital) detailing early experience using the Galaxy System, Noah Medical’s first commercial platform and a fully image-integrated solution for robotic navigated bronchoscopy.

加利福尼亚州圣卡洛斯，2024年4月18日（环球通讯社）--医疗机器人创新者诺亚医学今天分享了来自D.Kyle Hogarth医学博士（芝加哥大学医学中心）和Amit Mahajan医学博士（Inova Fairfax医院）的新现场数据，详细介绍了使用Galaxy系统的早期经验，Galaxy系统是诺亚医学的第一个商业平台，也是机器人导航支气管镜检查的完全图像集成解决方案。

The data represents findings from 165 total patient procedures investigating 190 total lesions. Key findings include: The papers reported diagnostic yield with a range of 92-96% observed by Dr. Hogarth and 96% by Dr. Mahajan.The average lesion size ranged from 14mm to 16mm, with more than one-third of them less than or equal to 10mm in size.Approximately 88% and 75% of lesions navigated to and biopsied by Dr.

这些数据代表了165例患者手术的结果，调查了190例总病变。主要发现包括：这些论文报告的诊断率范围为Hogarth博士观察到的92-96%，Mahajan博士观察到的96%。平均病变大小为14mm至16mm，其中三分之一以上小于或等于10mm。大约88%和75%的病变由Dr。

Hogarth and Dr. Mahajan, respectively, were found in the outer 1/3 or pleura of the lung.Overall, the average procedure time did not exceed 46 minutes at either location. The University of Chicago’s Dr. Kyle Hogarth was the first user of the Galaxy System in the United States. He specializes in the treatment of lung cancer and minimally invasive diagnosis and chose the Galaxy System for its benefits in biopsying peripheral lesions that are smaller in size and for its integrated imaging technology, allowing him to have real-time lesion updates with only a c-arm.

Hogarth和Mahajan博士分别在肺的外1/3或胸膜中发现。总体而言，两个地点的平均手术时间均不超过46分钟。芝加哥大学的凯尔·霍加斯博士是美国银河系的第一位用户。他专注于肺癌的治疗和微创诊断，并选择了Galaxy系统，因为它在活检尺寸较小的外周病变方面的优势以及其集成的成像技术，使他只需c臂即可实时更新病变。

“Using the Galaxy System over the past year, I have witnessed firsthand its incredible ability to correct for CT-to-body divergence and confirm tool-in-lesion through its integrated tomosynthesis technology, also known as TiLT Technology. Unlike 1st generation robots, we can do this without purchasing additional expensive imaging technologies,” said Dr.

“在过去的一年中，我使用Galaxy系统，亲眼目睹了它通过其集成的断层合成技术（也称为倾斜技术）纠正CT与身体的分歧并确认病变中的工具的难以置信的能力。与第一代机器人不同，我们可以做到这一点，而无需购买额外的昂贵成像技术，”Dr。

Hogarth. “I also appreciate the added confidence provided by .

霍加斯。“我也很感激你给我带来的更多信心。